Guidance: Human Prescription Drug and Biological Products–Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers–“Dose Banding”

TitleGuidance: Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--"Dose Banding"
ToC Doc Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--"Dose Banding"
Docket Number2022-15523
Type Notice
Subject Guidance:
Human Prescription Drug and Biological Products--Labeling for Dosing Based on Weight or Body Surface Area for Ready-to-Use Containers--"Dose Banding"
Publication Date2022-07-21
Last Updated Date 2022-07-20 08:15:10 -0400
Last Public Inspection2022-07-20
Filed At2022-07-20T08:45:00.000-04:00
PDF 2022-15523_PI.pdf (77377 bytes)
Download TXT / HTML / JSON
Number of Pages 5
Filing Typeregular
AgenciesFood and Drug Administration

You can find the raw source document below...

This site's data is aggregated programmatically and provided "as is" without any representations or warranties, express or implied. OFR.report is not affiliated with the Office of the Federal Register or the US government in any way.

© OFR.report 2021